Under construction – not a live service
Sign in
Taking people in BelgiumNo phase

Testing an intensive stroke therapy program delivered at home

Compares home-based and clinic-based intensive therapy in adults with chronic stroke.

Plain-language title generated from the registry record
Registry title: Implementation of a HABIT-ILE Intervention at Home for Chronic Stroke

Key facts

Where
Brussels, BelgiumSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Source: NCT05727111, who can take part

Where in Belgium

  • MSL-IN lab, IoNS, UCLouvainBrussels, BelgiumTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Université Catholique de Louvain
Trial code
NCT05727111
Record updated
9 May 2023
Original description
This study will use a randomized controlled trial design to assess the possible difference between two intensive treatment programs: a classic "Hand and Arm Bimanual Intensive Therapy Including Lower Extremities" (HABIT-ILE) therapy and a HABIT-ILE therapy implemented at the patient's home. Moreover, this study also aims to assess whether the patient's abilities are better with follow-up than without follow-up after two weeks of HABIT-ILE therapy. The possible difference between the therapies will be studied in terms of functional capacities, activities and social participation.Read full original descriptionShow less

Implementation of a HABIT-ILE Intervention at Home for Individuals With Chronic Stroke: a Non-inferiority Randomized Controlled Trial

This study will use a randomized controlled trial design to assess the possible difference between two intensive treatment programs: a classic "Hand and Arm Bimanual Intensive Therapy Including Lower Extremities" (HABIT-ILE) therapy and a HABIT-ILE therapy implemented at the patient's home. Moreover, this study also aims to assess whether the patient's abilities are better with follow-up than without follow-up after two weeks of HABIT-ILE therapy. The possible difference between the therapies will be studied in terms of functional capacities, activities and social participation.

Inclusion: Adults with a chronic stroke (older than 6 months); Ability to interact and understand simple instructions in order to complete assessments and therapy; Ability to perform a partial shoulder flexion or abduction, a partial elbow extension, and hold an object in the paretic hand; Availability of a caregiver for 6h30 per day during two weeks of therapy.

Exclusion: Botulinum toxin injection in the last 6 months before the first assessment or during the therapy; Intensive therapy in the last 6 months before the first assessment or during the therapy; Surgery that could affect the assessments or therapy in the last 6 months before the first assessment or during the therapy; Non controlled seizure; Severe visual or cognitive impairments interfering with treatment and or assessments.

ClinicalTrials.gov NCT05727111